Clinical Trial

Cardio-Oncology Registry

Study acronym: CONFUCIUS
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 29, 2020 (before its estimated June 1, 2022 completion). Its status may not reflect the trial's current state.
Summary
Cardio-oncology is an emerging field. Most of the data available have been issued from either retrospective analysis, industry data or pharmacovigilance data. These data sources include a number of bias. CONFUCIUS is a single tertiary centre prospective registry including all patients who have been referred for cardio-oncology assessemnt. The objectives are to provide a comprehensive vue of cardoi-oncology, enable to detect early signals of cardiotoxicity and enhance ancillary projetcts aiming at specific populations (e.g., type of cancer) and/or drugs.
Trial Details
NCT Number NCT04407780
Lead Sponsor European Georges Pompidou Hospital
Conditions Cancer, Cardiac Disease, Metabolic Syndrome, Arrhythmia, Heart Diseases
Enrollment 5,000 participants
Start Date 2017-01-01
Primary Completion 2022-06-01 (estimated)
Study Completion 2027-06-01 (estimated)
Updated on ClinicalTrials.gov 2020-05-29